Studies have found that emetine not only has a certain antiviral effect, but also can reduce the inflammatory response of patients by inhibiting the activity of NF-κB through IκBα phosphorylation, and can also reduce pulmonary hypertension by regulating various cellular processes (88). This evidence concerns the gene NFKBIA and pulmonary arterial hypertension.